J&J Settles With Montana for $5.9M in Risperdal Marketing Lawsuit

1
Subsidiaries of Johnson & Johnson have agreed to pay $5.9 million to settle Montana's lawsuit over the company's fraudulent marketing of Risperdal.  According to...

Joint Crisis Planning Results in Clinically Reasonable Choices

0
Analysis of 221 joint crisis plans for people with diagnoses of psychotic disorders and at least one psychiatric admission in the past two years,...

J&J Fighting Federal Risperdal Deal Over Language Regarding Breasts

5
Johnson & Johnson is negotiating with federal authorities over language that might be used in dozens of civil lawsuits regarding abnormal breast development and...

PA Court Affirms Dismissal of Paxil Wrongful Death Suit

1
A Pennsylvania Superior Court has affirmed a lower court's ruling that GlaxoSmithKline is not responsible for the congenital heart defect that lead Joanne Thomas...

Hospital Website Health Care Information May Not Be Reliable

4
An investigation found that many US hospital websites were more like advertising outlets than educational portals.

Risperdal Lawsuit Website Launched

3
A website has been launched by the firm of Bernstein Liebhard LLP, who are filing cases on behalf of men and young boys who allegedly...

California Senate Panel Investigates Drugging of Foster Kids

9
The chair of a state Senate committee told a public hearing that California’s foster care system “has grown more addicted to mind-altering medication."

Consumer Reports Recommends Against Antipsychotics for Depression

8
Consumer Reports recommends against antipsychotic "augmentation therapy" for depression. The consumer watchdog magazine finds that the unproven efficacy, harmful side effects, availability of alternatives,...

Shire Refocuses ADHD Drug To Treat Binge Eating

4
Shire, dissatisfied with the success - but not "resounding success" - of its amphetamine/amino acid combination Vyvanse, is developing the drug (which recently failed...

Forest Labs’ Antidepressant Marketing Woes Continue

1
Forest Labs has been hit with a new lawsuit in Massachusetts, over misleading marketing of its antidepressant drugs Celexa and Lexapro to adolescents, even...

Schizophrenia-Immune System “Link” Opens the Door to Research

3
"In order to expose people to dangerous treatments - and immunosuppresive drugs do carry risks - you need serious evidence to suggest those drugs...

J&J Takes Last Stab at $1.2B Risperdal Verdict

5
Lawyers for Johnson & Johnson took the stand in Arkansas today, a final effort at convincing the Arkansas Supreme Court to overturn a jury's...

PA Supreme Court Rules Pharmas Responsible for Defective Drugs

1
The Pennsylvania Supreme Court has ruled that pharmaceutical companies can be held liable for negligent design and marketing of drugs, agreeing with the family...

FDA Applies Uneven Standards to New Drugs’ Safety and Efficacy

1
A study in the Journal of the American Medical Association finds that, although "many patients and physicians assume that the safety and effectiveness of...

Department of Defense Reveals Forced Drugging of Detainees

1
A report from the Deputy Inspector General of the Department of Defense, obtained by Truthout under a Freedom of Information Act request, confirms that...

Bipartisan Agreement on Mental Health Treatment

7
The New York Times on Obama's $235 million initiative: "Mental health unites lawmakers Republican and Democrat, urban and rural, even those with safe seats...

FDA Investigator: “The Clinical Trial System is Broken”

4
A featured article in the British Medical Journal relates the perspective of FDA investigator Thomas Marciniak, who says “Drug companies have turned into marketing machines. They’ve kind of...

The Coming Tsunami of Mental Health Care for ‘Boomers

2
A report released yesterday by the Institute of Medicine, at the request of the U.S. Department of Health and Human Services, says "at least...

Tension Over Clinical Trial Data Disclosure Escalates

1
Pharmalot reviews the escalating tension over clinical trial data disclosure. The PhRMA trade group has come out in opposition to AllTrials, a petition drive...

When Science Goes Astray

3
The Los Angeles Times business section explores how it is possible that "so many scientists looking for cures to diseases have been building on...

Pain Meds Reduce Dementia Symptoms

0
British researchers find that a 10% increase in pain medication resulted in a dramatic reduction in the use of antipsychotic and other medications. “When...

NE Journal of Medicine Backs Congressional Call for Research Transparency

0
Rep. Ed Markey (D-MA) introduced the Trial and Experimental Studies Transparency (TEST) Act into congress on August 2, 2012; a bill aimed at closing...

Ohio to Review Antipsychotics in Foster and Other Children

0
The state of Ohio plans to invest $1 million in the next three years to review the use of psychiatric drugs prescribed to children,...

Sixty Percent of Canadian Clinical Trials Broke Rules

8
Canadian physicians and psychiatrists regularly do not report serious negative side effects during their clinical trials of drugs, according to an investigation by the...

Opposition to Murphy Bill Gains Traction in the House

11
The Murphy bill, which aims to defund or restructure federal initiatives on mental illness such as SAMHSA, as well as promote wider use of involuntary care...